期刊文献+

鼻咽癌发生与ABO血型分布的相关性研究 被引量:1

Study on association between the distribution of ABO blood type and nasopharyngeal carcinoma
下载PDF
导出
摘要 目的探究鼻咽癌的发生与ABO血型是否存在联系。方法将1 136例在中山大学肿瘤防治中心确诊为鼻咽癌并进行血型鉴定的患者纳入研究(鼻咽癌组),对鼻咽癌组与广州中医药大学第一附属医院2013年健康体检人群(对照组)的血型分布进行比较。结果鼻咽癌组与对照组之间的血型分布差异没有统计学意义(P=0.884),鼻咽癌组不同分期之间的血型分布差异也没有统计学意义(P=0.506)。结论 ABO血型与南方人群当中鼻咽癌的发生、鼻咽癌的分期尚无关联。 Objective To investigate possible association between the incidence of nasopharyngeal carcinoma(NPC)and ABO blood type.Methods pathologically confirmed NPC patients(NPC group)with a serologically determined blood group in Sun Yatsen University Cancer Center were reviewed retrospectively.The distribution of blood groups of the NPC group were compared with the distribution of blood groups of healthy donors(control group)admitted to the First Affiliated Hospital of Guangzhou TCM University in the year 2013.Results There was no significant difference between NPC group and the control group in terms of distribution of ABO blood groups(P=0.884),neither with NPC stages(P=0.506).Conclusion In this study,we found that blood type has no association with an increased risk of NPC and NPC stages in a population of Southern China.
出处 《国际检验医学杂志》 CAS 2017年第18期2554-2555,2558,共3页 International Journal of Laboratory Medicine
关键词 鼻咽癌 ABO血型 流行病学 nasopharyngeal carcinoma ABO blood groups epidemiology
  • 相关文献

参考文献4

二级参考文献32

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2陈铃,姜衡春,申卫东,肖晓兰.ABO血型与恶性肿瘤相关性分析[J].四川肿瘤防治,2004,17(3):131-133. 被引量:23
  • 3杨世明,杨枨林,解华.恶性肿瘤ABO血型抗原强度变化的观察[J].第四军医大学学报,1994,15(6):474-475. 被引量:6
  • 4张平,孙胜.4种常见恶性肿瘤与ABO血型关系的初步分析[J].中国输血杂志,1989,2(1):20-21. 被引量:7
  • 5[2]Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cellfree Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma[J]. Cancer Res, 1999, 59(6):1188~1191
  • 6[3]Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumor DNA in blood (plasma/serum) of cancer patients[J]. Cancer Metastasis Rev, 1999, 18(1): 65~73
  • 7[4]Mutirangura A, Pomthanakasem W, Theamboonlers A, et al.Epstein-Barr viral DNA in serum of patients in nasopharyngeal carcinoma[J]. Clin Cancer Res, 1998, 4(3): 665~669
  • 8[5]Shotelesuk K, Khorprasert C, Sakdikul S, et al. Epstein-Bart viral DNA in serum/plasma as a tumor marker for nasopharyngeal carcinoma[J]. Clin Cancer Res, 2000, 6(3): 1046~1051
  • 9[6]Lo YM, Leung SF, Chan LY, et al. Kinetics of plasma EpsteinBarr virus DNA during radiation therapy for nasopharyngeal carcinoma[J]. Cancer Res, 2000, 60(9): 2351~2355
  • 10[8]Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Bart virus DNA [J]. Cancer Res, 2000, 60 (24): 6878~6881

共引文献46

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部